Biography and Research Information
OverviewAI-generated summary
Mohammad Mamun Alam is a microbiologist specializing in virology. His research has focused on the development of novel antiviral therapies, including monoclonal antibody-based treatments and combination therapies for HIV-1. He has investigated the construction, purification, and expression of cell line-based anti-HIV-1 antibodies (IgG, Fab, scFvs), as well as the potential of small antibodies and fusion inhibitors as anti-retroviral agents.
His recent work includes computational studies on antiviral agents, such as pyrazole derivatives targeting Chikungunya virus and repurposing approaches for SARS-CoV-2 variants. Alam has also contributed to studies on immune responses to COVID-19 vaccines in Bangladeshi populations and the molecular epidemiology of respiratory syncytial virus (RSV) in children. He has experience in leading research teams and collaborating with local and international organizations, including CEPI.
Metrics
- h-index: 6
- Publications: 17
- Citations: 102
Selected Publications
-
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines (2025)
Collaboration Network
Top Collaborators
Mohammed Ziaur Rahman
International Centre for Diarrhoeal Disease Research (BD)
7 shared publications
- An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus
- Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Pre COVID-19 molecular epidemiology of respiratory syncytial virus (RSV) among children in Bangladesh
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Showing 5 of 7 shared publications
Rubhana Raqib
International Centre for Diarrhoeal Disease Research (BD)
5 shared publications
- Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Mustafizur Rahman
International Centre for Diarrhoeal Disease Research (BD)
5 shared publications
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Pre COVID-19 molecular epidemiology of respiratory syncytial virus (RSV) among children in Bangladesh
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Muntasir Alam
International Centre for Diarrhoeal Disease Research (BD)
4 shared publications
- Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Md. Belayet Hasan Limon
University of Louisville (US)
4 shared publications
- Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
- Potent Inhibition of Chikungunya Virus Entry by a Pyrazole–Benzene Derivative: A Computational Study Targeting the E1–E2 Glycoprotein Complex
Asma Salauddin
International Centre for Diarrhoeal Disease Research (BD)
4 shared publications
- Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
- Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Mohammad Enayet Hossain
International Centre for Diarrhoeal Disease Research (BD)
3 shared publications
- An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah Virus
- Pre COVID-19 molecular epidemiology of respiratory syncytial virus (RSV) among children in Bangladesh
- Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
Protim Sarker
International Centre for Diarrhoeal Disease Research (BD)
3 shared publications
- Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
Mustafizur Rahman
International Centre for Diarrhoeal Disease Research (BD)
3 shared publications
- Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population
- Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
Dipok Kumer Shill
International Centre for Diarrhoeal Disease Research (BD)
3 shared publications
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Shafina Jahan
International Centre for Diarrhoeal Disease Research
3 shared publications
In database
- <i>S</i>-Adenosyl-<scp>l</scp>-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Md Jowel Rana
International Centre for Diarrhoeal Disease Research (BD)
3 shared publications
- Beta, Delta, and Omicron, Deadliest Among SARS-CoV-2 Variants: A Computational Repurposing Approach
- Development and Validation of a Standardized Pseudotyped Virus based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
- Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines
Mark Manak
Coalition for Epidemic Preparedness Innovations (NO)
2 shared publications
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
Luc Gagnon
Nexen (Canada) (CA)
2 shared publications
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
Steven Phay-Tran
Nexen (Canada) (CA)
2 shared publications
- Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis
- Standardization and Harmonization of SARS-COV-2 Assays Offered by the CEPI Centralized Laboratory Network in Support for Vaccine Clinical Trials
Similar Researchers
Based on overlapping research topics
Bahaa Mustafa
University of Arkansas for Medical Sciences
Monoclonal and Polyclonal Antibodies Research
SARS-CoV-2 and COVID-19 Research
Computational Drug Discovery Methods
Jennings Boyette
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Viral Infections and Vectors
Immune Response and Inflammation
Michael Kidd
University of Arkansas at Fayetteville
HIV/AIDS Research and Interventions
SARS-CoV-2 and COVID-19 Research
Viral Infections and Vectors
Renita Brown
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Viral Infections and Vectors
Immune Response and Inflammation
James Craig Forrest
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Viral Infections and Vectors
Immune Response and Inflammation
A. Adams
University of Central Arkansas
HIV/AIDS Research and Interventions
SARS-CoV-2 and COVID-19 Research
Public Health Research